KEQUHIGH SIGNALFINANCIAL10-K

KEQU shows dramatic balance sheet expansion with total liabilities surging 63.5% while net income plummeted 39.2%, indicating potential acquisition activity or operational strain.

The massive increase in liabilities combined with declining profitability and cash burn suggests either a significant acquisition (supported by the new Nu Aire product mentions) or deteriorating operational efficiency. The 58.9% inventory surge and 38.4% accounts receivable increase amid falling net income indicates potential working capital management issues or integration challenges that warrant immediate investor attention.

Comparing 2025-07-02 vs 2024-06-28View on EDGAR →
FINANCIAL ANALYSIS

KEQU's financials show classic signs of acquisition activity with total assets growing 44.4% and liabilities expanding 63.5%, while cash declined 35.8% from $23.3M to $14.9M. Despite gross profit increasing 32.3% to $68.9M, net income fell sharply by 39.2% to $11.4M and operating cash flow dropped 24.4%, suggesting integration costs or operational inefficiencies. The substantial increases in inventory (58.9%) and accounts receivable (38.4%) combined with deteriorating profitability metrics signal potential working capital strain that could pressure future performance.

FINANCIAL STATEMENT CHANGES
Total Liabilities
Balance Sheet
+63.5%
$78.6M$128.4M

Liabilities grew 63.5% — significant increase in debt or obligations, assess impact on financial flexibility.

Inventory
Balance Sheet
+58.9%
$20.7M$32.8M

Inventory surged 58.9% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Total Assets
Balance Sheet
+44.4%
$134.8M$194.7M

Asset base grew 44.4% — expansion through organic growth, acquisitions, or capital deployment.

Net Income
P&L
-39.2%
$18.8M$11.4M

Net income declined 39.2% — review whether driven by operations, interest costs, or non-recurring items.

Accounts Receivable
Balance Sheet
+38.4%
$45.1M$62.4M

Receivables surged 38.4% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Cash & Equivalents
Balance Sheet
-35.8%
$23.3M$14.9M

Cash declined 35.8% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Gross Profit
P&L
+32.3%
$52.1M$68.9M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Current Liabilities
Balance Sheet
+31.7%
$40.8M$53.7M

Current liabilities surged 31.7% — significant near-term obligations; verify ability to meet short-term debt.

Operating Cash Flow
Cash Flow
-24.4%
$19.6M$14.8M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Current Assets
Balance Sheet
+22.3%
$96.8M$118.4M

Current assets grew 22.3% — improving short-term liquidity or inventory/receivables build.

LANGUAGE CHANGES
NEW — 2025-07-02
PRIOR — 2024-06-28
ADDED
As of June 24, 2025, the registrant had outstanding 2,844,290 shares of Common Stock.
Management's Discussion and Analysis of Financial Condition and Results of Operations 16 Item 7A.
("Nu Aire") complements Kewaunee Scientific's existing portfolio through Nu Aire's biological safety cabinets, CO2 incubators, ultralow freezers, and other essential laboratory products.
Our International subsidiaries, as identified in Note 1 , Summary of Significant Accounting Policies , of the Notes to Consolidated Financial Statements included in Item 8 of this Annual Report on 10-K, provide products and services, including facility design, detailed engineering construction, and project management from the planning stage through testing and commissioning of laboratories.
We hold various patents and patent rights, but do not consider that our success or growth is dependent upon our patents or patent rights.
+7 more — sign up free →
REMOVED
As of June 24, 2024, the registrant had outstanding 2,840,143 shares of Common Stock.
Management's Discussion and Analysis of Financial Condition and Results of Operations 14 Item 7A.
On average, payments for our products are received during the quarter following shipment, with the exception of the retention amounts which are collected at the final completion of the project.
Sales for two of the Company's domestic dealers and our national stocking distributor represented, in the aggregate, approximately 42% and 35% of the Company's sales in fiscal years 2024 and 2023, respectively.
Our order backlog at April 30, 2024 was $155.6 million, as compared to $147.9 million at April 30, 2023.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →